Status:
COMPLETED
ECGI in Patients With Persistent Atrial Fibrillation
Lead Sponsor:
Pacific Rim Electrophysiology Research Institute
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-85 years
Brief Summary
To determine the values and limitations of ECGI in guiding ablation and risk stratification in patients with persistent atrial fibrillation.
Detailed Description
The patient population will include symptomatic persistent AF patients (N=50). The total of fifty patients will be studied to determine: * The values and limitations of ECGI in identifying atrial fib...
Eligibility Criteria
Inclusion
- Patients are diagnosed as persistent AF. Persistent AF was defined as continuous AF from 7 days to 12 months and long- lasting AF beyond twelve months.
- Patients who are symptomatic
- Patients who are willing to sign consent and be followed post procedure in an out- patient arrhythmia clinic
Exclusion
- Patients under 18 years or over 85 years of age.
- Patients with chronic alcoholism.
- Recent myocardial infarction within one month of the study.
- Significant debilitating diseases or a terminal disease.
- Patients with documented left atrial thrombus.
- Medical or mental conditions precluding a long-term follow-up.
Key Trial Info
Start Date :
February 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03836092
Start Date
February 23 2018
End Date
April 1 2022
Last Update
April 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bumrungrad International Hospital
Bangkok, Thailand